These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8418768)
1. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause? Triplett DA Arch Pathol Lab Med; 1993 Jan; 117(1):78-88. PubMed ID: 8418768 [TBL] [Abstract][Full Text] [Related]
2. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies]. Barbui T; Finazzi G; Galli M Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316 [TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Galli M Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297 [TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome]. Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118 [TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988 [TBL] [Abstract][Full Text] [Related]
12. More about the link between thrombosis and atherosclerosis in autoimmune diseases: triglycerides and risk for thrombosis in patients with antiphospholipid antibodies. Garrido JA; Peromingo JA; Sesma P; Pia G J Rheumatol; 1994 Dec; 21(12):2394. PubMed ID: 7699654 [No Abstract] [Full Text] [Related]
13. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
14. The Italian Registry of Antiphospholipid Antibodies. Finazzi G Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095 [TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?]. Kisiel E; Kryczka W Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic antiphospholipid antibodies and their clinical significance]. Palester-Chlebowczyk M Acta Haematol Pol; 1994; 25(2 Suppl 2):67-74. PubMed ID: 7998477 [TBL] [Abstract][Full Text] [Related]
17. [The antiphospholipid syndrome and antiphospholipid antibodies]. Malícková K; Fucíková T Cas Lek Cesk; 2001 Aug; 140(15):465-8. PubMed ID: 11569167 [TBL] [Abstract][Full Text] [Related]
18. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies. Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980 [TBL] [Abstract][Full Text] [Related]
19. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471 [TBL] [Abstract][Full Text] [Related]